DNA POLYMERASE MUTANT SUITED TO NUCLEIC ACID AMPLIFICATION FROM RNA

    公开(公告)号:US20240309341A1

    公开(公告)日:2024-09-19

    申请号:US18660667

    申请日:2024-05-10

    申请人: Takara Bio Inc.

    IPC分类号: C12N9/12

    CPC分类号: C12N9/1252 C12Y207/07007

    摘要: Provided are: a DNA polymerase mutant having reverse transcriptase activity, the DNA polymerase mutant including a sequence consisting of twelve specific amino acids A1-A12, wherein the DNA polymerase mutant having reverse transcriptase activity is characterized in that the A3 and/or A10 amino acid is substituted by a basic amino acid residue different from that prior to the introduction of mutation; a kit and a composition including the DNA polymerase; a method for producing the DNA polymerase; and a method for modifying an existing DNA polymerase having reverse transcriptase activity.

    siRNA EXPRESSION VECTOR
    3.
    发明申请

    公开(公告)号:US20220372516A1

    公开(公告)日:2022-11-24

    申请号:US17767195

    申请日:2020-10-09

    申请人: TAKARA BIO INC.

    摘要: Provided is a nucleic acid construct for expressing a gene of interest, the nucleic acid construct comprising, in order from 5′-terminus, each sequence of: (a) a 5′ long terminal repeat (LTR) sequence derived from a retrovirus; (b) a packaging signal sequence (IV) derived from a retrovirus; (c) a sequence or multiple cloning site of the gene of interest; (d) a post-transcriptional regulatory sequence (PRE); (e) an siRNA generating sequence which forms at least one stem-loop structure and in which RNA, which induces RNA interference in mammalian cells, is transcribed; and (f) a 3′ LTR sequence derived form a retrovirus.

    OLIGONUCLEOTIDE PRESERVATION METHOD

    公开(公告)号:US20210164018A1

    公开(公告)日:2021-06-03

    申请号:US16616532

    申请日:2018-06-06

    申请人: TAKARA BIO INC.

    IPC分类号: C12Q1/6806 C07K14/245

    摘要: The present invention pertains to: an oligonucleotide preservation method; and a kit comprising an oligonucleotide. The present invention provides a method for stably preserving an oligonucleotide-containing solution by adding a nucleic acid-binding protein to said oligonucleotide-containing solution in advance.

    METHOD FOR PRODUCING ENDOTHELIAL CELLS
    8.
    发明申请

    公开(公告)号:US20200071675A1

    公开(公告)日:2020-03-05

    申请号:US16465920

    申请日:2017-12-01

    申请人: TAKARA BIO INC.

    IPC分类号: C12N5/071 A01N1/02

    摘要: The present invention relates to a method for producing endothelial cells, including carrying out: (a) inducing a population of mesoderm-lineage cells containing endothelial progenitor cells from pluripotent stem cells without forming an embryoid body; and (b) culturing the population of mesoderm-lineage cells containing endothelial progenitor cells in the presence of RepSox, in this order. According to the present invention, endothelial cells with high quality can be efficiently produced from pluripotent stem cells. The endothelial cells obtained by the method of the present invention are useful for the production of, for example, a myocardial sheet, and expected to be utilized in the treatment of a heart disease. A myocardial sheet can be produced by mixing the endothelial cells obtained by the method of the present invention with myocardial cells and mural cells and culturing the cells.